
Nano-X Imaging Ltd. NNOX
$ 3.01
-4.44%
Annual report 2024
added 01-17-2026
Nano-X Imaging Ltd. Accounts Payables 2011-2026 | NNOX
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Nano-X Imaging Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.21 M | 3.3 M | 3.62 M | 3.13 M | 435 K | 475 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.62 M | 435 K | 2.2 M |
Quarterly Accounts Payables Nano-X Imaging Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3.13 M | - | - | - | 435 K | - | - | - | 475 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.13 M | 435 K | 1.35 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
34.8 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
AxoGen
AXGN
|
8.01 M | $ 31.85 | 2.68 % | $ 1.41 B | ||
|
Cognyte Software Ltd.
CGNT
|
25.2 M | $ 8.97 | -1.59 % | $ 644 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Apyx Medical Corporation
APYX
|
2.71 M | $ 3.89 | -2.51 % | $ 135 M | ||
|
Alphatec Holdings
ATEC
|
53 M | $ 16.95 | -4.48 % | $ 2.42 B | ||
|
Bio-Rad Laboratories
BIO
|
122 M | $ 312.8 | -0.23 % | $ 8.83 B | ||
|
CONMED Corporation
CNMD
|
102 M | $ 41.19 | -0.91 % | $ 1.27 B | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.69 | -9.12 % | $ 138 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 50.26 | 3.85 % | $ 7.49 K | ||
|
Boston Scientific Corporation
BSX
|
960 M | $ 91.09 | 3.43 % | $ 134 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
4.2 B | $ 121.01 | -0.61 % | $ 211 B | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
InMode Ltd.
INMD
|
13.8 M | $ 13.79 | -1.11 % | $ 1.09 B | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
2.67 M | $ 27.84 | 0.04 % | $ 235 M | ||
|
Second Sight Medical Products
EYES
|
817 K | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
109 M | $ 165.75 | -3.35 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
34 M | $ 0.81 | -3.78 % | $ 83.2 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
1.34 M | $ 13.82 | -5.67 % | $ 374 M | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.68 | 0.24 % | $ 122 M | ||
|
IRadimed Corporation
IRMD
|
1.9 M | $ 102.68 | 0.67 % | $ 1.3 B | ||
|
Integer Holdings Corporation
ITGR
|
101 M | $ 84.87 | -1.06 % | $ 2.85 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
LivaNova PLC
LIVN
|
69.7 M | $ 62.45 | 0.55 % | $ 3.39 B | ||
|
Globus Medical
GMED
|
75.1 M | $ 92.68 | -0.85 % | $ 12.6 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 11.98 | -3.51 % | $ 923 M | ||
|
Aziyo Biologics
AZYO
|
2.28 M | - | 1.37 % | $ 20.5 M | ||
|
Pulmonx Corporation
LUNG
|
3.83 M | $ 1.78 | 0.28 % | $ 69.6 M |